U.S. market Closed. Opens in 1 day 8 hours 37 minutes

PMCB | PharmaCyte Biotech, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2024-04-302023-04-302022-04-302021-04-302020-04-302019-04-302018-04-302017-04-302016-04-302015-04-302014-04-302013-04-302012-04-302011-04-302010-04-302009-04-302008-04-302007-04-302006-04-302005-04-302004-04-302003-04-302002-04-30
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A12.16K66.56K126.00K262.93K653.13K1.19M1.17M537.04K86.37K2.38KN/AN/A
Cost of RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A9.62K19.38K32.10K228.66K427.41K266.20K171.01KN/A41.40K780.00N/AN/A
Gross ProfitN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A2.54K47.17K93.89K34.27K225.72K923.75K998.65K537.04K44.97K1.60KN/AN/A
Operating Expenses8.52M6.46M4.39M3.62M3.83M4.10M6.98M4.44M6.07M13.70M18.98M1.69M2.00M482.25K2.14M6.27M4.67M4.61M7.87M4.21M1.72M32.13K29.85K
Selling, General & Admin2.12M5.99M3.70M2.71M3.53M3.64M4.98M3.26M4.67M10.22M18.98M1.69M2.00M473.05K1.65M5.79M4.26M4.47M7.75M3.10M313.94K32.13KN/A
Research & Development407.43K468.54K690.94K916.25K301.22K460.05K2.00M1.18M1.41M3.48M323.00N/AN/A9.21K492.46K473.51K412.88K133.84K119.01K1.11M1.41MN/AN/A
Other Operating ExpensesN/A202.00K-4.28K-1.19K-40.0033.40K152.59K2.52M10.54K3.34M-5.89M2.59K1.22M103.90KN/A4.07MN/AN/AN/AN/AN/AN/A29.85K
Operating Income-6.52M-6.46M-4.39M-3.62M-3.83M-4.10M-6.98M-4.44M-6.07M-13.70M-18.98M-1.68M-1.95M-388.36K-2.11M-6.04M-3.75M-3.61M-7.34M-4.16M-1.72M-32.13K-29.85K
Other Expenses / Income6.85M2.14M152.85K71.75K-493.0033.40K152.59K-1.54K9.35K2.84M-8.27M86.26K49.87K-837.69K-3.88M471.00-42.72K-6.79K-1.76M-114.04K1.73MN/AN/A
Before Tax Income333.76K-4.32M-4.24M-3.55M-3.83M-4.07M-6.83M-4.44M-6.06M-10.85M-27.25M-1.60M-1.66M-1.23M-5.70M-6.03M-3.82M-3.60M-9.03M-4.15MN/AN/AN/A
Income Tax ExpensesN/A-1.94M-153.36K3.05K453.00-33.40K-152.59K-4.44K-4.88K4.94K19.96K154.42K-49.87K1.01M3.88M-471.0042.72K6.79K2.05M114.04K1.72M32.13K29.85K
Net Income333.76K-4.32M-4.09M-3.55M-3.83M-4.07M-6.83M-4.44M-6.06M-10.85M-27.25M-1.60M-1.90M-1.40M-5.99M-6.04M-3.79M-3.61M-9.39M-4.28M-1.72M-32.13K-29.85K
Interest ExpensesN/AN/A509.003.05K453.00N/AN/A1.54K1.19K4.94K21.05K154.42K241.25K171.66K292.56K27.18KN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding9.58M19.49M15.52M1.45M903.81K733.40K645.76K563.54K501.60K469.79K389.01K294.12K249.97K233.68K200.97K134.68K112.01K108.34K91.16K69.27K62.95K58.70K58.70K
Diluted Shares Outstanding9.58M19.49M15.52M1.45M903.81K733.40K646.08K563.82K501.85K469.79K389.01K294.12K249.97K233.68K200.97K134.68K112.01K108.34K91.16K69.27K62.95K58.70K58.70K
EBITDAN/AN/AN/AN/A-3.83MN/AN/A-4.44MN/A-9.92M-27.23M-1.68M-1.63M-388.36K-2.11M-5.99M-3.78M-3.61M-7.33M-1.72M-1.73M-32.13K-29.85K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-13,851.65%-2,454.11%-308.23%-802.09%-916.45%-317.88%-308.31%-1,365.76%-1,994.19%-72,685.35%0.00%0.00%
EBIT333.76K-6.25M-4.24M-3.55M-3.83M-4.10M-6.98M-4.45M-6.07M-10.84M-27.21M-1.29M-1.71M-216.70K-1.82M-6.01M-3.75M-3.61M-7.34M-4.16MN/AN/AN/A
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-10,602.55%-2,566.09%-171.99%-690.83%-920.93%-315.07%-308.42%-1,365.85%-4,819.57%0.00%0.00%0.00%
Financial Year End2024-04-302023-04-302022-04-302021-04-302020-04-302019-04-302018-04-302017-04-302016-04-302015-04-302014-04-302013-04-302012-04-302011-04-302010-04-302009-04-302008-04-302007-04-302006-04-302005-04-302004-04-302003-04-302002-04-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙